🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase II, randomized, double-blind, placebo-controlled, parallel-...
Status
Completed
Location
Multiple Locations
Start Date
2010-11
Trial ID
NCT01225393
Treatments Being Tested
Behçet's disease (BD) is a multi-system auto inflammatory disorder with vas...
Status
Completed
Location
Assiut University Hospitals
Start Date
2024-01-01
Trial ID
NCT06730958
Treatments Being Tested
The Phase 1 study described herein will evaluate the safety, tolerability, ...
Status
Recruiting
Location
Xencor Investigative Site
Start Date
2024-10-10
Trial ID
NCT06619990
To assess the safety and immune response to two experimental vaccines when ...
Status
Completed
Location
JHU AVEG
Start Date
TBD
Trial ID
NCT00001096
Treatments Being Tested
This study is a prospective Bayesian adaptive randomized phase II clinical ...
Status
Recruiting
Location
2nd Affiliated Hospital, School of Medicine, Zhejiang University, China
Start Date
2025-01-01
Trial ID
NCT06936046
Treatments Being Tested
This is a multicenter, randomized, double-blind, parallel group study to co...
Status
Terminated
Location
First Hospital of Shanxi Medical University
Start Date
2018-11-16
Trial ID
NCT03670888
This is a randomized, double-blind, double-dummy study of single dose HDIT1...
Status
Completed
Location
emovis GmbH
Start Date
2019-11-15
Trial ID
NCT04165122
Treatments Being Tested
A Phase 1, first in human (FIH), single-centre, double-blind, randomized, p...
Status
Terminated
Location
HMR
Start Date
2022-04-14
Trial ID
NCT05323110
The purpose of the study is to examine efficacy and safety of epcoritamab w...
Status
Terminated
Location
UW Cancer Center at ProHealth Care
Start Date
2023-03-06
Trial ID
NCT05660967
Treatments Being Tested
The study hypothesis is that a "reinforced" pneumococcal combined vaccine s...
Status
Completed
Location
Pôle de Médecine Interne, Centre de référence " Maladies systémiques et autoimmunes rares, en particulier Vascularites nécrosantes et Sclérodermies systémiques " Hôpital Cochin, Assistance Publique-Hôpitaux de Paris
Start Date
2018-02-05
Trial ID
NCT03069703